Literature DB >> 32515512

European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis.

J P Thyssen1,2, C Vestergaard3, M Deleuran3, M S de Bruin-Weller4, T Bieber5, A Taieb6, J Seneschal6, M J Cork7, C Paul8, C Flohr9, S Weidinger10, M Trzeciak11, T Werfel12, A Heratizadeh12, S Barbarot13, U Darsow14, D Simon15, A Torrelo16, P V Chernyshov17, J-F Stalder18, C Gelmetti19, Z Szalai20, Å Svensson21, L B von Kobyletzki22,23, L De Raeve24, R Fölster-Holst25, S Cristen-Zaech26, D Hijnen27, U Gieler28, J Ring29, A Wollenberg30,31.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32515512     DOI： 10.1111/jdv.16716

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  7 in total

1.  Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.

Authors:  Jonathan I Silverberg; Eric L Simpson; Mark Boguniewicz; Marjolein S De Bruin-Weller; Peter Foley; Yoko Kataoka; Gaëlle Bégo-Le-Bagousse; Zhen Chen; Brad Shumel; Jingdong Chao; Ana B Rossi
Journal:  Acta Derm Venereol       Date:  2021-11-10       Impact factor: 3.875

Review 2.  Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.

Authors:  Thomas Bieber
Journal:  Nat Rev Drug Discov       Date:  2021-08-20       Impact factor: 84.694

3.  Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies.

Authors:  Marjolein De Bruin-Weller; Tilo Biedermann; Robert Bissonnette; Mette Deleuran; Peter Foley; Giampiero Girolomoni; Jana Hercogová; Chih-Ho Hong; Norito Katoh; Andrew E Pink; Marie-Aleth Richard; Stephen Shumack; Juan F Silvestre; Stephan Weidinger
Journal:  Acta Derm Venereol       Date:  2021-02-17       Impact factor: 3.875

4.  Anti-atopic dermatitis effects of Parasenecio auriculatus via simultaneous inhibition of multiple inflammatory pathways.

Authors:  Yujin Kwon; Su-Yeon Cho; Jaeyoung Kwon; Min Hwang; Hoseong Hwang; Yoon Jin Kang; Hyeon-Seong Lee; Jiyoon Kim; Won Kyu Kim
Journal:  BMB Rep       Date:  2022-06       Impact factor: 5.041

5.  Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort.

Authors:  Stine Elsgaard; Anna Kathrine Danielsen; Jacob P Thyssen; Mette Deleuran; Christian Vestergaard
Journal:  Int J Womens Dermatol       Date:  2021-07-22

6.  Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis.

Authors:  Jonathan I Silverberg; H Chih-Ho Hong; Jacob P Thyssen; Brian M Calimlim; Avani Joshi; Henrique D Teixeira; Eric B Collins; Marjorie M Crowell; Scott J Johnson; April W Armstrong
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-18

7.  Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.

Authors:  Jonathan I Silverberg; David N Adam; Matthew Zirwas; Sunil Kalia; Jan Gutermuth; Andreas Pinter; Andrew E Pink; Andrea Chiricozzi; Sebastien Barbarot; Thomas Mark; Ann-Marie Tindberg; Stephan Weidinger
Journal:  Am J Clin Dermatol       Date:  2022-07-20       Impact factor: 6.233
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.